Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of remimazolam anesthesia for day surgery
ChiCTR2600115968Phase 4Not yet recruiting
- Sponsor
- Zhangzhou Municipal Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative pain, Perioperative anxiety and None (2 arms), sponsored by Zhangzhou Municipal Hospital. Primary endpoint: Time to eye opening. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative painPerioperative anxiety
Beyond the preview
Go deeper on ChiCTR2600115968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600115968.